// App-Quantinova.ai

P570 : Improvements in subcomponents of the inflammatory bowel disease questionnaire in patients treated with vedolizumab: Results from GEMINI trial data

Researchers

Presenter

  • D T Rubin

Principal Investigators

  • D Tudor

  • J M Khalid

  • H Patel

Medical Centers

  • University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA

  • Takeda Pharmaceutical International AG, Zürich, Switzerland

  • Takeda Development Centre Europe Ltd., Evidence and Value Generation, London, UK

Locations

  • United States

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved